Tumours with <85% EGFR staining had a significantly better survival time (87.0 months (69.0–103.0)) (P<0.001) compared to tumours overexpressing the protein (35.0 months (23.0–58.0)) (Figure 3). This evidence concerns the gene EGFR and neoplasm.